Get started

Release

Apple’s iPhone 16 Launch: Post-Event Pullback?Looking at the weekly chart (1W) of Apple (AAPL) with the vertical lines marking the dates of iPhone launch events, we can attempt to identify a more consistent pattern around these events. Key Observations: Pre-Launch Price Rally: In nearly all the iPhone launch events, we observe a notable pre-event rally. This suggests that investors tend to buy Apple stock in anticipation of the product reveal, leading to upward momentum in the weeks leading up to the launch. Magnitude of Rally: In many cases, the stock gains significant value leading up to the event, as investors and traders speculate on the success of the new product. Post-Launch Behavior: Short-Term Pullbacks: A clear pattern emerges where, immediately after the event, Apple's stock often experiences a pullback or consolidation. This appears to be a classic "sell the news" reaction, where investors who had bought the stock in anticipation of the event sell to lock in profits. For example, following the iPhone 12 and iPhone 13 launches, we saw short-term pullbacks lasting a few weeks. Long-Term Trend Continuation: Despite the short-term corrections, the long-term trajectory of AAPL tends to remain upward. After most iPhone launches, even if there is a post-event pullback, the stock eventually resumes its upward trend. This long-term bullish trend suggests that Apple’s underlying business remains strong, supported by sustained iPhone sales and other product lines. More Defined Patterns: Pre-Launch Rally: Across most launches (iPhone 6, 7, X, and 12 in particular), the stock rallies leading up to the event by 10-15% on average. This suggests a strong investor confidence buildup before the actual product reveal. Post-Event Decline: In many instances (notably the iPhone 6s, 7, and 12), there is a consistent 5-10% decline after the launch. This sell-off usually lasts a few weeks to a couple of months, after which the stock resumes its longer-term upward trajectory. Current iPhone 16 Presentation (Today): Pre-Event Setup: Currently, AAPL has shown some weakness in the weeks leading up to the iPhone 16 presentation. The stock has pulled back slightly, breaking the pattern of a strong pre-launch rally seen in previous years. Technical Indicators: The MACD is showing some bearish momentum, which suggests that the stock might be due for a further pullback post-launch, consistent with the historical pattern of profit-taking after these events. Potential Short-Term and Long-Term Strategy: Short-Term: Given the clear pattern of a post-event pullback, traders might anticipate a brief decline following today’s iPhone 16 presentation. This would align with the past pattern where Apple stock typically declines by 5-10% after the launch. Long-Term: Despite short-term volatility, Apple’s long-term uptrend has remained intact. Investors who are more focused on the long-term may consider any post-launch correction as a buying opportunity, as AAPL tends to resume its upward trend within a few weeks to months after these events. Conclusion: The most consistent pattern around Apple’s iPhone launch events is a pre-launch rally followed by a post-launch pullback. This sell-the-news behavior often creates a short-term decline, but Apple’s long-term growth trajectory remains strong. For today’s iPhone 16 presentation, based on historical data, we may see a similar short-term correction, but long-term investors could view this as an opportunity to add to their positions.
NASDAQ:AAPL
by alfredomares2019
OP LongAfter a long wait, I am currently waiting for this pair to give me my confirmation for a long position. Price already in my area of value, just waiting for the market to tell me to get in on a Buy. Buy bias for the coming Months. Hello Friends! - --------------- **First Scenario - Long:** Initial Target: $3.3 Entry: $2.4 Stoploss: 2.2 **Second Scenario - Short:** It's already tested at $3 in price. Less probability of going down, but if you're shorting, double-check your stop loss. In a general bear market, prices can drop to $1.8 or $1.6 if they go below $2.2 level. - --------------- Take into consideration: Holders have been rising since the start of the year. Psychological Resistance at $4 Psychological Support at $1.8 - --------------- NFA DYOR Good Luck! ⚠️Caution: Just because I've set my buy and sell position Settings or drawn direction lines on my chart doesn't indicate I've opened a position or am obsessed with a particular bias. This is only a forecast; I don't trade when the price reaches my level; I have rules of engagement. Perhaps the most crucial element is 🆘RISK MANAGEMENT🆘.
Long
by irfanp056
1
KEY ECONOMIC REPORTS TO PLAN AND PROFIT FROM TRADING INDICESOANDA:NAS100USD A quick search for Actionable economic data results in overwhelming results leading to analysis paralysis. Today we'll list some of the reports we watch out for and hopefully you'll profit from the same 1.Non-Farm Payroll Top of our list is NFP Monthly report showing changes in U.S. jobs. Drives Fed policy and indicates economic growth. 2.Earnings Releases Lists changes in earnings of publicly traded companies, which can move the market 3.CPI (Consumer Price Index) Measures inflation or cost-of-living changes through average price of a basket of goods and services. 3.Federal Reserve open market operations Indicates the buying and selling of securities by U.S. central banks as a tool of monetary policy. 4.U.S. Unemployment Report Presents U.S. unemployment rate as percentage. Drives Fed policy and indicates economic strength. 5.FOMC (Federal Open Markets Committee) Determines U.S. monetary policy and whether to move the key interest rate. Drives stock market movements. 6.Industrial production Tracks change in monthly raw volume of industrial goods produced. 7.Inventory reports Tracks changes in oil and natural gas supplies. Impacts energy prices paid by consumers.
OANDA:NAS100USD
by HURSTCAPITAL
ZCoin released "fair" Proof-of-Work algorithmToday ZCoin announced the release of Merkle Tree Proof, a new Proof-of-Work algorithm which will be activated on the December 10. This POW is designed to fight against cryptocurrency mining centralization like ASIC farms. The aim is to level the playing field between people with huge amount of computing power (such as mining farms) and those with little power. This, obviously, might help ZCoin to get less centralized increasing the demand and popularity of the coin, resulting in the increase in price. Currently ZCash is trading near btc 0.0015 support, where it is forming a double bottom. Yet the double bottom pattern hasn’t been confirmed as the break below is still possible. However, the RSI oscillator shows bullish divergence, suggesting a potential upside move. If price will remain above the 0.0015 support, ZCoin is likely to move upwards and should be reaching 61.8% Fibonacci. This is btc 0.0038 resistance level, and if XZC will rise that high, the result will be a 160% gain over the Bitcoin. However, break below the support could have a negative affect on the XZC/BTC, obviously making it much riskier investment. All-in-all, fundamental news are positive and ZCoin might be the coin of interest in the coming days/weeks.
X
by CryptalDash
AUD/USD soars on fundamentalsDaily outlook - AUD/USD soars on fundamentals In line with expectations, the AUD/USD currency pair left a descending triangle formation in the downward direction. Most probably, the rate could continue to move it this direction, but a release of information on the US CPI led to 30-pips depreciation of the Greenback. After markets will calm down, the pair most likely is going to try to use the 100-hour SMA near 0.7892 to return into formation and resume the fall in accordance with the general market sentiment, which remains 58% bearish. The fact that the buck will attempt to return some of the lost value is also supported by many technical indicators, which point out that the pair is heavily overbought. Finally, the presence of the 200-hour SMA near 0.7923 additionally complicates the road upstairs.
by UnknownUnicorn890690
ViaDerma, Inc. Commences First Manufacturing Run and will Meet tLOS ANGELES, CA--(Marketwired - June 12, 2017) - ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has commenced manufacturing of its FDA registered topical antibiotic. ViaDerma, Inc. has completed the quality control and approved labeling for the product and will begin distribution of the wound care drug in June. The "Quality Control" plan has been executed and now meets the strict guidelines starting with the manufacturer all the way through to the point of purchase. To assure a solid growth strategy, the Company's go to market expert and strategist, Ivan Klarich, has just returned from multi country Asian tour for ViaDerma where the product was well received. The Company is expecting several countries to order 10,000 units to begin the product launch in several Asian countries. The Company plans to continue to add additional products and offer those new products directly to the same distributors. The Company plans to announce additional new products for its proprietary specialty pharmaceutical product line in the very near future. The Company's President, Dr. Christopher Otiko, said, "We are all pleased to have a product in manufacturing and to meet our goals. Our product manufacturer will be able to manufacture most of our products and we look forward to building a lasting relationship to deliver high quality pharmaceuticals to our distributors. Since my presentation at DFCON or the Diabetic Foot Global Conference in Houston, TX, in March, we have had a tremendous amount of interest in our topical antibiotic. Our goal is to have our product added to all diabetic foot ulcer treatment protocols around the globe." About ViaDerma, Inc. ViaDerma, Inc. (OTC PINK: VDRM) is a publicly traded specialty pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas. ViaDerma's lead product, a tetracycline-based topical antibiotic, uses an innovative transdermal delivery method that allows for application of active ingredients in a topical form. This patent-pending dual carrier transdermal technology may be applied in products within the medical and cosmetic markets. Also, a patent application using the combination of CBD's and THC with the delivery system was filed in 2017. The use of CBD's is for the reduction of inflammation and for the treatment of several diseases, such as, nicotine addiction, fibromyalgia, Cohn's disease, schizophrenia, migraine headaches, pain management for cancer and Multiple Sclerosis. For more information, please visit: www.viadermalicensing.com Forward Looking Statements Forward-Looking Statements certain statements in this release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified using words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements. The Company's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors. We assume no obligation to update the information contained in this news release.
OTC:VDRMLong
by Cryptocol